CVE-2026-113678: froxlor froxlor

Froxlor before 2.3.15 Symlink Following Privilege Escalation via Traffic Cron

CVSS 9.4 CriticalCriticalEPSS 0.0063 · 50th percentile

Critical, because:

CVSS score 9.4: 9.0 or more.

Published by the CVE Program (CNA: VulnCheck) at 20 Oct 2026, 15:40 UTC. agentprime has not analysed this yet, so whether it affects any app is not known. This CVE names a vendor and product rather than a package, so the lockfile check doesn’t match it.

Affected products, as the CNA wrote them
Vendor	Product	Versions
froxlor	froxlor pkg:composer/froxlor/froxlor	affected before 2.3.15 semver Other versions: unaffected

Identifiers

CVE-2026-113678

CNA

VulnCheck

Weakness (CWE)

CWE-59

Not analysed yet

We haven’t published our own analysis of this CVE. If a person reviews it, this page will say what’s affected and what has to be true for it to matter.

Severity and exploitation

Score	Rating	CVSS	Vector	Source
9.4	Critical	4.0	CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H	CNA (VulnCheck)Used for this record
9.9	Critical	3.1	CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H	CNA (VulnCheck)

CISA KEV Not listed.
EPSS 0.0063, the 50th percentile, on 5 Nov 2026: FIRST’s estimate of the chance of exploitation in the next 30 days.

Timeline

This record came from the full history of the CVE Program, published 20 Oct 2026. New records show when each source confirmed them.

Sources

References from the CNA

github.com/froxlor/froxlor/security/advisories/GHSA-vwjv-x8ff-4cvv vendor-advisory
github.com/froxlor/froxlor/commit/0805a7e16a223d528b51d8cacfaff54217b9d8f8 patch
github.com/froxlor/froxlor/releases/tag/2.3.15 release-notes
github.com/froxlor/froxlor/blob/2.3.14/lib/Froxlor/Http/Statistics.php#L144-L162 technical-description
www.vulncheck.com/advisories/froxlor-before-2.3.15-symlink-following-privilege-escalation-via-traffic-cron third-party-advisory

Facts on this page come from the CVE List as the CNA published them, with CVSS from the sources named above, CISA KEV and FIRST EPSS. Vendors, products and versions are shown as the CNA wrote them. We don’t reproduce the CVE’s description.